We are live on ! Find out more
APLT

Applied Therapeutics
APLT

Delisted

APLT was delisted on the 2nd of February, 2026.

Back to rankings

36 hedge funds and large institutions have $15.6M invested in Applied Therapeutics in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

4% more capital invested

Capital invested by funds: $15.1M → $15.6M (+$570K)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.88% less ownership

Funds ownership: 40.95% → 40.07% (-0.88%)

5% less funds holding

Funds holding: 38 → 36 (-2)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

Holders
36
Holders Change
-2
Holders Change %
-5.26%
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
11
Reduced
9
Closed
9
Calls
$3.46M
Puts
–
Net Calls
+$3.46M
Net Calls Change
+$3.38M

Top Buyers

Rank Fund Capital Flow
1
SAM
Simplify Asset Management
Nevada
+$2.35M
2
KCM
Knoll Capital Management
Florida
+$985K
3
Citigroup
Citigroup
New York
+$348K
4
RSCM
Rock Springs Capital Management
Maryland
+$181K
5
Millennium Management
Millennium Management
New York
+$118K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$2.32M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$462K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$355K
4
AG
Artal Group
Luxembourg
-$304K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$98.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
PIA
26
Perennial Investment Advisors
California
$9.41K – – –
EFS
27
Essex Financial Services
Connecticut
$8.11K +$9.85K +10,000 New
TRCT
28
Tower Research Capital (TRC)
New York
$6K +$1.7K +1,730 +34%
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$1.35K -$1.43K -1,451 -46%
Group One Trading
30
Group One Trading
Illinois
$406 -$576 -585 -54%
Bank of America
31
Bank of America
North Carolina
$296 +$232 +236 +183%
Wells Fargo
32
Wells Fargo
California
$221 +$5 +5 +2%
Morgan Stanley
33
Morgan Stanley
New York
$159 -$4.22K -4,284 -96%
FDCDDQ
34
Federation des caisses Desjardins du Quebec
Quebec, Canada
$68 – – –
Barclays
35
Barclays
United Kingdom
$9 +$11 +11 New
O
36
OrbiMed
New York
– -$2.32M -3,050,921 Closed
AG
37
Artal Group
Luxembourg
– -$304K -400,000 Closed
Bank of Montreal
38
Bank of Montreal
Ontario, Canada
– -$355K -323,100 Closed
PVI
39
Pura Vida Investments
New York
– -$77.3K -101,654 Closed
E
40
Ergoteles
New York
– -$27.8K -36,524 Closed
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
– -$16.7K -21,931 Closed
Jane Street
42
Jane Street
New York
– -$13.5K -17,707 Closed
TSS
43
Two Sigma Securities
New York
– -$8.31K -10,933 Closed
Citadel Advisors
44
Citadel Advisors
Florida
– -$284 -374 Closed
Simplex Trading
45
Simplex Trading
Illinois
– +$134 +136 New
1
2

APLT Hedge Fund Activity: Q1 2023 in Review

36 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q1 2023, worth a combined $15.6M — up 3.8% from $15.1M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of APLT and 7 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 11 added.

The largest buyer was Simplify Asset Management, opening a new position worth an estimated $2.35M. The largest seller was OrbiMed, exiting entirely with an estimated $2.32M sold.

  • 36 institutional investors held Applied Therapeutics (APLT) as of Q1 2023, down from 38 in Q4 2022.
  • Funds reported $15.6M of Applied Therapeutics stock for Q1 2023, up 3.8% quarter-over-quarter.
  • 7 funds opened new Applied Therapeutics positions in Q1 2023 and 9 closed out, a net change of -2 holders.
  • The largest Applied Therapeutics buyer in Q1 2023 was Simplify Asset Management, an estimated $2.35M added.
  • The largest Applied Therapeutics seller in Q1 2023 was OrbiMed, an estimated $2.32M sold.

Based on aggregated 13F filings for Q1 2023.